| 1 | Corticosteroid or NSAID | - | - | - | - | 1件: 46 46 |
| 2 | Non-steroidal anti-inflammatory drug (NSAID) | - | - | - | - | 1件: 46 46 |
| 3 | Non-steroidal anti-inflammatory drugs (NSAIDs) | - | - | - | - | 1件: 107 107 |
| 4 | NSAID | - | - | - | - | 1件: 271 271 |
| 5 | NSAIDs | - | - | - | - | 4件: 46 46, 70, 107, 271 |
| 6 | NSAIDs (permitted,not necessary) | - | - | - | - | 1件: 46 46 |
| 7 | NSAIDs and sulfasalazine | 1件: Sulfasalazine Sulfasalazine | 1件: D00448
D00448
| - | - | 1件: 271 271 |
| 8 | Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac | 1件: Etodolac Etodolac | 1件: D00315
D00315
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
| 9 | Other Non-selective NSAIDs | - | - | - | - | 1件: 271 271 |
| 10 | Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses | - | - | - | - | 1件: 46 46 |